| The diagnosis and management of food allergy and food intolerances JL Turnbull, HN Adams, DA Gorard Alimentary pharmacology & therapeutics 41 (1), 3-25, 2015 | 436 | 2015 |
| The UKPBC risk scores: derivation and validation of a scoring system for longterm prediction of endstage liver disease in primary biliary cholangitis M Carbone, SJ Sharp, S Flack, D Paximadas, K Spiess, C Adgey, ... Hepatology 63 (3), 930-950, 2016 | 385 | 2016 |
| International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ... Nature communications 6 (1), 8019, 2015 | 318 | 2015 |
| Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome DA Gorard, GW Libby, MJG Farthing Alimentary pharmacology & therapeutics 8 (2), 159-166, 1994 | 242 | 1994 |
| Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. DA Gorard, JB Hunt, JJ Payne-James, KR Palmer, RG Rees, ML Clark, ... Gut 34 (9), 1198-1202, 1993 | 203 | 1993 |
| Intestinal transit in anxiety and depression. DA Gorard, JE Gomborone, GW Libby, MJ Farthing Gut 39 (4), 551-555, 1996 | 201 | 1996 |
| Effect of a tricyclic antidepressant on small intestinal motility in health and diarrhea-predominant irritable bowel syndrome DA Gorard, GW Libby, MJG Farthing Digestive diseases and sciences 40, 86-95, 1995 | 188 | 1995 |
| 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. DA Gorard, GW Libby, MJ Farthing Gut 35 (4), 496-500, 1994 | 158 | 1994 |
| Ambulatory small intestinal motility in'diarrhoea'predominant irritable bowel syndrome. DA Gorard, GW Libby, MJ Farthing Gut 35 (2), 203-210, 1994 | 155 | 1994 |
| Escalating polypharmacy DA Gorard Journal of the Association of Physicians 99 (11), 797-800, 2006 | 143 | 2006 |
| Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score M Carbone, A Nardi, S Flack, G Carpino, N Varvaropoulou, C Gavrila, ... The Lancet Gastroenterology & Hepatology 3 (9), 626-634, 2018 | 134 | 2018 |
| An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs HJ Cordell, JJ Fryett, K Ueno, R Darlay, Y Aiba, Y Hitomi, M Kawashima, ... Journal of hepatology 75 (3), 572-581, 2021 | 107 | 2021 |
| Oral methotrexate in ulcerative colitis JRF Cummings, KR Herrlinger, SPL Travis, DA Gorard, AS McIntyre, ... Alimentary pharmacology & therapeutics 21 (4), 385-389, 2005 | 98 | 2005 |
| Prevalence of irritable bowel syndrome in chronic fatigue JE Gomborone, DA Gorard, PA Dewsnap, GW Libby, MJG Farthing Journal of the Royal College of Physicians of London 30 (6), 512, 1996 | 80 | 1996 |
| Contrasting liver function test patterns in obstructive jaundice due to biliary structures and stones JO Hayat, CJ Loew, KN Asrress, AS McIntyre, DA Gorard Qjm 98 (1), 35-40, 2005 | 78 | 2005 |
| Intestinal motor function in irritable bowel syndrome DA Gorard, MJG Farthing Digestive Diseases 12 (2), 72-84, 1994 | 71 | 1994 |
| Autoimmune hepatitis triggered by nitrofurantoin: a case series S Appleyard, R Saraswati, DA Gorard Journal of medical case reports 4, 1-5, 2010 | 65 | 2010 |
| Migrating motor complex and sleep in health and irritable bowel syndrome DA Gorard, CK Vesselinova-Jenkins, GW Libby, MJG Farthing Digestive diseases and sciences 40, 2383-2389, 1995 | 58 | 1995 |
| Effective treatment of diabetic diarrhoea with somatostatin analogue, octreotide. FH Mourad, D Gorard, AV Thillainayagam, D Colin-Jones, MJ Farthing Gut 33 (11), 1578-1580, 1992 | 57 | 1992 |
| General practitioner and hospital specialist attitudes to functional gastrointestinal disorders LM Gladman, DA Gorard Alimentary pharmacology & therapeutics 17 (5), 651-654, 2003 | 56 | 2003 |
